MaaT Pharma S.A.
MAAT.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | €73 | €111 | €90 | €81 |
| - Cash | €15 | €20 | €31 | €24 |
| + Debt | €14 | €16 | €17 | €14 |
| Enterprise Value | €72 | €107 | €76 | €71 |
| Revenue | €2 | €1 | €2 | €1 |
| % Growth | 62.3% | -13.1% | 102.5% | – |
| Gross Profit | €2 | -€0 | €1 | €0 |
| % Margin | 67.4% | -5.1% | 68.8% | 30.1% |
| EBITDA | -€15 | -€16 | -€13 | -€11 |
| % Margin | -603% | -1,101.7% | -734.4% | -1,329.9% |
| Net Income | -€15 | -€16 | -€13 | -€11 |
| % Margin | -621.5% | -1,073.4% | -747% | -1,327.3% |
| EPS Diluted | -1 | -1.15 | -1.05 | -0.97 |
| % Growth | 13% | -9.5% | -8.2% | – |
| Operating Cash Flow | -€15 | -€9 | -€13 | -€6 |
| Capital Expenditures | -€0 | -€1 | -€0 | -€1 |
| Free Cash Flow | -€16 | -€10 | -€13 | -€6 |